Triazoles

Mycology
Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Triazoles and Six Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)
A. Espinel-Ingroff, D. J. Diekema, A. Fothergill, E. Johnson, T. Pelaez, M. A. Pfaller, M. G. Rinaldi, E. Canton, J. Turnidge
Bacteriology
MIC Quality Control Guidelines and Disk Diffusion Test Optimization for CEM-101, a Novel Fluoroketolide
Ronald N. Jones, James E. Ross, Paul R. Rhomberg
and and the Quality Control Working Group
Mycology
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion
M. A. Pfaller, D. J. Diekema, D. L. Gibbs, V. A. Newell, D. Ellis, V. Tullio, A. Rodloff, W. Fu, T. A. Ling
and and the Global Antifungal Surveillance Group
Mycology
Activity of MGCD290, a Hos2 Histone Deacetylase Inhibitor, in Combination with Azole Antifungals against Opportunistic Fungal Pathogens
M. A. Pfaller, S. A. Messer, N. Georgopapadakou, L. A. Martell, J. M. Besterman, D. J. Diekema
Mycology
Wild-Type MIC Distribution and Epidemiological Cutoff Values for Aspergillus fumigatus and Three Triazoles as Determined by the Clinical and Laboratory Standards Institute Broth Microdilution Methods
M. A. Pfaller, D. J. Diekema, M. A. Ghannoum, J. H. Rex, B. D. Alexander, D. Andes, S. D. Brown, V. Chaturvedi, A. Espinel-Ingroff, C. L. Fowler, E. M. Johnson, C. C. Knapp, M. R. Motyl, L. Ostrosky-Zeichner, D. J. Sheehan, T. J. Walsh
and for the Clinical and Laboratory Standards Institute Antifungal Testing Subcommittee
Mycology
Comparison of 24-Hour and 48-Hour Voriconazole MICs as Determined by the Clinical and Laboratory Standards Institute Broth Microdilution Method (M27-A3 Document) in Three Laboratories: Results Obtained with 2,162 Clinical Isolates of Candida spp. and Other Yeasts
Ana Espinel-Ingroff, E. Canton, J. Peman, M. G. Rinaldi, A. W. Fothergill
Mycology
Reliability of the Vitek 2 Yeast Susceptibility Test for Detection of In Vitro Resistance to Fluconazole and Voriconazole in Clinical Isolates of Candida albicans and Candida glabrata
Brunella Posteraro, Rosa Martucci, Marilena La Sorda, Barbara Fiori, Dominique Sanglard, Elena De Carolis, Ada Rita Florio, Giovanni Fadda, Maurizio Sanguinetti
CASE REPORTS
Mucor circinelloides as a Cause of Invasive Maxillofacial Zygomycosis: an Emerging Dimorphic Pathogen with Reduced Susceptibility to Posaconazole
Zia U. Khan, Suhail Ahmad, Arnost Brazda, Rachel Chandy
Mycology
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing
M. A. Pfaller, D. J. Diekema, D. L. Gibbs, V. A. Newell, H. Bijie, D. Dzierzanowska, N. N. Klimko, V. Letscher-Bru, M. Lisalova, K. Muehlethaler, C. Rennison, M. Zaidi
and the Global Antifungal Surveillance Group
Mycology
In Vitro Survey of Triazole Cross-Resistance among More than 700 Clinical Isolates of Aspergillus Species
M. A. Pfaller, S. A. Messer, L. Boyken, C. Rice, S. Tendolkar, R. J. Hollis, D. J. Diekema

Pages